Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    Log In

    Show
    Forgot your password?
    Log In
    Or create a new account (it's free)

    Forgot Password?

    Enter your email address and we'll send you a link to reset your password.

    Get New Password

    Sign In Required

    To save favorites, you must log in.

    Creating an account is free, easy, and takes about 60 seconds.

    Already have an MDCalc account?

    Login to link your favorites and recently used calcs

    Show
    Forgot your password?
    Log In
    Or continue to Nuance

    Attention COACH STUDY participants:

    The principal investigators of the study request that you use the official version of the modified score here.

    UCSF-CAPRA Score for Prostate Cancer Risk

    Predicts outcomes of patients post-treatment for prostate cancer.
    Pearls/Pitfalls

    A prognostic score for prostate cancer, incorporating both the PSA and Gleason Score, designed to be both simple but with an accuracy comparable with the best nomograms.

    < 50 years
    0
    ≥ 50 years
    +1
    <6
    0
    ≥6 - 10
    +1
    ≥10 - 20
    +2
    ≥20 - 30
    +3
    >30
    +4
    No 4 or 5 pattern present
    0
    4 or 5 pattern in secondary
    +1
    4 or 5 pattern in primary
    +3
    T1 or T2
    0
    T3a
    +1
    <34%
    0
    ≥34%
    +1

    Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights
    Dr. Matthew R. Cooperberg

    About the Creator

    Matthew R. Cooperberg, MD, MPH, is an associate professor of urology and epidemiology/biostatistics at UCSF. He practices on the urologic oncology team of the UCSF Helen Diller Family Comprehensive Cancer Center, Mount Zion Medical Center and also operates at San Francisco General Hospital. Dr. Cooperberg researches primarily prostate cancer with a focus on effectiveness of emerging biomarkers on diagnosis and risk assessment, and relative benefits of treatment strategies on cost effectiveness and quality of life.

    To view Dr. Matthew R. Cooperberg's publications, visit PubMed

    Are you Dr. Matthew R. Cooperberg? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
    MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.
    About the Creator
    Dr. Matthew R. Cooperberg
    Are you Dr. Matthew R. Cooperberg?